Compare · CERS vs ZS
CERS vs ZS
Side-by-side comparison of Cerus Corporation (CERS) and Zscaler Inc. (ZS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CERS and ZS operate in EDP Services (Technology), so they compete in similar markets.
- ZS is the larger of the two at $35.94B, about 78.9x CERS ($455.4M).
- Over the past year, CERS is up 33.5% and ZS is down 32.2% - CERS leads by 65.7 points.
- ZS has been more active in the news (6 items in the past 4 weeks vs 1 for CERS).
- ZS has more recent analyst coverage (25 ratings vs 4 for CERS).
- Company
- Cerus Corporation
- Zscaler Inc.
- Price
- $2.17-3.56%
- $207.40-5.93%
- Market cap
- $455.4M
- $35.94B
- 1M return
- -18.27%
- +5.03%
- 1Y return
- +33.54%
- -32.21%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1997
- 2018
- News (4w)
- 1
- 6
- Recent ratings
- 4
- 25
Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.
Zscaler Inc.
Zscaler, Inc. operates as a cloud security company worldwide. The company provides Zscaler Internet Access solution that provides users, servers, operational technology, Internet of Things device secure access to externally managed applications, including software-as-a-service (SaaS) applications and Internet destinations; and Zscaler Private Access solution, which is designed to provide access to managed applications hosted internally in data centers, and private or public clouds. It also offers Zscaler Digital Experience that measures end-to-end user experience across business applications, as well as provides an easy to understand digital experience score for each user, application, and location within an enterprise. In addition, the company provides workload segmentation solutions comprising Zscaler Cloud Security Posture Management that identifies and remediates application misconfigurations in SaaS, infrastructure as a service, and platform as a service to reduce risk and ensure compliance with industry and organizational benchmarks; and Zscaler Cloud Workload Segmentation, which is designed to secure application-to-application communications inside public clouds and data centers to stop lateral threat movement, as well as prevents application compromise and reduces the risk of data breaches. Its platform modules include Zscaler Central Authority, Zscaler Enforcement Node, and Zscaler Log Servers. It serves customers in airlines and transportation, conglomerates, consumer goods and retail, financial services, healthcare, manufacturing, media and communications, public sector and education, technology, and telecommunications services industries. The company was formerly known as SafeChannel, Inc., and changed its name to Zscaler, Inc. in August 2008. Zscaler, Inc. was incorporated in 2007 and is headquartered in San Jose, California.
Latest CERS
- Cerus Corporation Announces Workshop and Abstracts at the 2026 AABB Annual Meeting
- Chief Legal Officer Jensen Chrystal sold $89,529 worth of shares (30,000 units at $2.98) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 936,657 units (SEC Form 4)
- SEC Form S-8 filed by Cerus Corporation
- SEC Form 10-Q filed by Cerus Corporation
- Cerus Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Cerus Corporation Announces Second Quarter 2026 Financial Results
- Chief Executive Officer Jayaraman Vivek K sold $52,665 worth of shares (16,666 units at $3.16) as part of a pre-agreed trading plan, decreasing direct ownership by 0.74% to 2,232,211 units (SEC Form 4)
- Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026
- Cerus Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Chief Financial Officer Green Kevin Dennis sold $99,105 worth of shares (33,676 units at $2.94) as part of a pre-agreed trading plan and gave a grant of 63,600 shares, decreasing direct ownership by 8% to 1,062,188 units (SEC Form 4) to cover withholding tax
Latest ZS
- SEC Form 4 filed by Zscaler Inc.
- SEC Form 8-K filed by Zscaler Inc.
- Zscaler Hosts 2026 Investor Day, Reaffirms First Quarter and Fiscal 2027 Guidance
- Zscaler Collaborates with IBM and Red Hat to Protect Private Applications from Frontier AI-Powered Threats
- New Zscaler Report Reveals AI-Assisted Attackers Move to Massive Data Theft, Executive Targeting, and Millions in Extortion Payments
- Chief Financial Officer Rubin Kevin sold $102,390 worth of shares (519 units at $197.28) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 42,768 units (SEC Form 4)
- SEC Form 144 filed by Zscaler Inc.
- Zscaler Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Zscaler Appoints Ross Tackett as Chief Revenue Officer
- Zscaler to Host Investor Day on October 6